Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Booth

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Physical Anthropology|July 1, 1981
Deciduous tooth dimensions in fetal rhesus monkeys from mothers with induced diabetesK A Bennett, J M Cheverud, S N Booth
Gut|October 1, 1973
Serum carcinoembryonic antigen in clinical disordersS N Booth, J P King, J C Leonard, et al.
Lancet (London, England)|December 23, 1978
Carcinoembryonic antigen concentrations in undiagnosed patientsK R Hine, S N Booth, J C Leonard, et al.
Journal of Clinical Pathology|June 1, 1977
Cancer-associated proteins in effusion fluidsS N Booth, G Lakin, P W Dykes, et al.
British Medical Journal|October 26, 1974
Carcinoembryonic antigen in management of colorectal carcinomaS N Booth, G C Jamieson, J P King, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1993
Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?C M Bate, S N Booth, J P Crowe, et al.
Journal of Clinical Pathology|February 1, 1974
The effect of serum protein concentrations on the specificity of the radioimmunoassay of carcinoembryonic antigen in malignant neoplasia and non-neoplastic diseaseJ M Crawley, B E Northam, J P King, et al.
British Medical Journal|January 26, 1980
Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigenP W Dykes, K R Hine, A R Bradwell, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1989
Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcerF I Lee, S N Booth, K M Cochran, et al.
Gut|April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator GroupC M Bate, S N Booth, J P Crowe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Physical Anthropology|July 1, 1981
Deciduous tooth dimensions in fetal rhesus monkeys from mothers with induced diabetesK A Bennett, J M Cheverud, S N Booth
Gut|October 1, 1973
Serum carcinoembryonic antigen in clinical disordersS N Booth, J P King, J C Leonard, et al.
Lancet (London, England)|December 23, 1978
Carcinoembryonic antigen concentrations in undiagnosed patientsK R Hine, S N Booth, J C Leonard, et al.
Journal of Clinical Pathology|June 1, 1977
Cancer-associated proteins in effusion fluidsS N Booth, G Lakin, P W Dykes, et al.
British Medical Journal|October 26, 1974
Carcinoembryonic antigen in management of colorectal carcinomaS N Booth, G C Jamieson, J P King, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1993
Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?C M Bate, S N Booth, J P Crowe, et al.
Journal of Clinical Pathology|February 1, 1974
The effect of serum protein concentrations on the specificity of the radioimmunoassay of carcinoembryonic antigen in malignant neoplasia and non-neoplastic diseaseJ M Crawley, B E Northam, J P King, et al.
British Medical Journal|January 26, 1980
Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigenP W Dykes, K R Hine, A R Bradwell, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1989
Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcerF I Lee, S N Booth, K M Cochran, et al.
Gut|April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator GroupC M Bate, S N Booth, J P Crowe, et al.
Pageof 1